| mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0056 |
0.9 |
| mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0055 |
0.9 |
| mRNA |
NU-7441 |
GDSC1000 |
pan-cancer |
AAC |
-0.0056 |
0.9 |
| mRNA |
CI-976 |
CTRPv2 |
pan-cancer |
AAC |
0.0059 |
0.9 |
| mRNA |
VX-680 |
CTRPv2 |
pan-cancer |
AAC |
0.016 |
0.9 |
| mRNA |
CBB-1007 |
CTRPv2 |
pan-cancer |
AAC |
0.0079 |
0.9 |
| mRNA |
Bortezomib |
GDSC1000 |
pan-cancer |
AAC |
0.0072 |
0.9 |
| mRNA |
Rapamycin |
GDSC1000 |
pan-cancer |
AAC |
-0.0073 |
0.9 |
| mRNA |
WAY-362450 |
CTRPv2 |
pan-cancer |
AAC |
0.0054 |
0.9 |
| mRNA |
piperlongumine |
GDSC1000 |
pan-cancer |
AAC |
0.0047 |
0.9 |